on 10 Jan 2023
Last Applicant/ Owned by
Kernal Biologics, Inc.
700 Main Street
Cambridge, Massachusetts, 02139
Serial Number
UK00003866276 filed on 10th Jan 2023
Registration Number
UK00003866276 registered on
7th Apr 2023
Correspondent Information
Carpmaels & Ransford LLP
One Southampton Row
London,
WC1B 5HA
Chemicals for use in medicines, biologics, vaccines, biotherapeutics, biosimilars and therapeutics research, product development and manufacturing processes; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in research, product development and the manufacture of pharmaceuticals for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analysing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labelling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acid sequencers for scientific purposes; polypeptide encoding nucleic acids for laboratory use.
Medical, biological, and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites.
Medical and scientific research services in the fields of nucleic acid sciences for medical, scientific and technological applications; design, engineering, research, development, consultation and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; design, engineering, research, development, consultation and testing services in the field of mRNA sciences for medical, scientific and technological applications; research and development services of new medical, technological and scientific products, treatments and techniques for others in the fields of mRNA; consultation services in the field of mRNA research, mRNA engineering, mRNA pharmaceutical development.
UK00003866276
Word
Individual